The Claim

In rat L6 myoblasts, knockdown of the vitamin D receptor (VDR) reduces the expression of MyoD by 44% and Myogenin by 64% under vehicle conditions, and treatment with 1,25-dihydroxyvitamin D3 at 10 pM or higher reverses this suppression.

Source: 1,25‐Dihydroxyvitamin D3 Mediates L6 Myoblast Differentiation via Vitamin D Receptor (VDR)

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

When scientists reduce a specific vitamin D sensor in rat muscle cells, the cells make less of two important muscle-building proteins—but giving them a tiny amount of active vitamin D brings those proteins back up.

See the scientific wording

In rat L6 myoblasts, knockdown of the vitamin D receptor (VDR) reduces expression of MyoD and Myogenin by 44% and 64%, respectively, under vehicle conditions, but this suppression is reversed by treatment with 1,25-dihydroxyvitamin D3 at 10 pM or higher.

What the research says

1 study
  1. Study: 1,25‐Dihydroxyvitamin D3 Mediates L6 Myoblast Differentiation via Vitamin D Receptor (VDR)

    Scientists turned off the vitamin D receptor in rat muscle cells, which made key muscle genes weaker — but when they added a strong form of vitamin D (even in tiny amounts), those genes bounced back. This matches what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.